IPBC Asia
Thompson Reuters #IO 13145

Tweets

August 27

This is interesting: "SEP-reliant industries have the fastest quality-adjusted price declines in the U.S. economy". https://t.co/FzsjWTnG23

August 27

Despite this week's PTAB setback the Bass/Spangenberg IPR war with Big Pharma is far from over. http://t.co/TjIOGrvKsO

August 27

There is still a long way to go in the Bass/Spangenberg campaign against big pharma http://t.co/VStBIkNeVy

Blog

27 Aug 2015
Big pharma scores first victory in IPR battle with Bass and Spangenberg, but the war is far from over

As anyone keeping score will know it’s currently big pharma 2 – Kyle Bass/Erich Spangenberg 0. The decision earlier this week by the Patent Trial and Appeal Board (PTAB) not to institute inter partes reviews of two patents owned by pharmaceutical company Acorda undoubtedly comes as a blow to the hedge fund investor and IP licensing expert, who have been behind the patent story of...

27 Aug 2015
Microsoft’s Android licensing bonanza may be on downward trajectory after Korean Nokia deal approval

Following 21 months of review, South Korea’s Fair Trade Commission (FTC) this week gave its stamp of approval to Microsoft’s €5.4 billion-plus (over $7.2 billion) takeover of Nokia’s mobile devices and services unit, which completed in April last year. However, it has imposed a set of fairly stringent conditions to its decision with regards to patent and technology...

06 Aug 2015
Amazon cloud contract IP warning tops most read blogs of the year so far list as we take a summer break

After a very busy seven months, the IAM blog is now taking its annual summer break. We’ll be back reporting on 27th August. For those of you not enjoying a holiday this month, here are a few stats to chew on. According to Google Analytics we have had 77,107 unique users since 1st January, who between them have visited us 138,254 times. The top 10 countries for visitors are (in order):...

Explore the current issue

Assessing patent renewal decisions in the United States and Europe

Global patent filings continue to grow; but the rate at which applications and granted patents are abandoned may provide more meaningful insights into the way in which these myriad assets are being used – or not used – by their owners
Matthew Beers and Maria Lazarova

The world's leading patent practitioners

IAM Patent 1000

The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.

Visit site

The world's leading IP strategists

IAM Strategy 300

A directory of individuals identified following a detailed research process as global leaders in providing IP value creation expertise to rights owners.

Visit site
IAM Market
Market intelligence

Market intelligence

Annual IAM supplements and management reports that take an in-depth look at specific areas of IP value creation concern and opportunity.

Visit site
IPBC

IPBC

Unique in the global IP marketplace, IPBC events bring together corporate leaders, aggregators, investors and other intermediaries to discuss key issues, network and do deals.

Visit site
IP Hall of Fame

IP Hall of Fame

A project designed to recognise the outstanding contributions that individual men and women have made towards the creation of today’s global IP system.

Visit site
Upcoming event

Upcoming event

IPBC Asia, November 8-10 2015 – Tokyo, Japan This is the only event in the region that focuses on how IP owners can strategically use intellectual property to secure greater operational flexibility, drive revenues, enhance bottom-line returns, increase shareholder value and provide leverage in the financial markets.

View all events
Subscribe

Subscribe

IAM is a unique publication which focuses on the many ways in which intellectual property and intangible assets can be used to create corporate value.

Subscribe now
International reports

International reports

Weekly updates from IAM’s team of international correspondents looking at recent developments in IP law and practice, business and finance.

Visit site